Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
STXS · NYSE · Electromedical & Electrotherapeutic Apparatus
$0.9422−0.0678 (−6.71%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Stereotaxis (STXS) · oqro.io/stocks/STXS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director purchased ~$100K of STXS shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director purchased ~$25K of STXS shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 18, 2026
Director purchased ~$11K of STXS shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 18, 2026
Director purchased ~$240 of STXS shares in the open marketSource5%+ stake, activist · Stake as of Nov 9, 2026 · Filed Nov 12, 2026
Dr. Nathan Fischel disclosed a 15.3% stake in STXS and may seek to influence the companySourceInsider trade · Traded Mar 10, 2025 · Filed Mar 11, 2025
Director purchased ~$69K of STXS shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
Director purchased ~$42K of STXS shares in the open marketSourceInsider trade · Traded Mar 7, 2025 · Filed Mar 10, 2025
Director purchased ~$2.7K of STXS shares in the open marketSource